|Title:||Elimination of lymphatic filariasis in the South-East Asia Region : Report of the Tenth Meeting of the RPRG, Dili, Timor-Leste, 25-27 June 2013|
|Authors:||World Health Organization, Regional Office for South-East Asia|
|Publisher:||WHO Regional Office for South-East Asia|
|Place of publication:||New Delhi|
|Abstract:||The Tenth Meeting of Regional Programme Review Group (RPRG) was organized by the WHO Regional Office for South-East Asia in Dili, Timor-Leste, from 25 to 27 June 2013, for the elimination of LF. The Group reviewed the progress and identified the operational and technical issues and suggested appropriate remedial measures to nine endemic countries in the South-East Asia (SEA) Region. The Group approved a total of 571.01 million ALB, and 1111 and 101.74 million DEC tablets of 200 mg from GSK and Sanofi Pharma, respectively. The meeting recommended a capacity building workshop for programme managers, particularly for ensuring quality data, data management and transmission assessment survey (TAS), and expansion of RPRG for other NTDs in the Region. Endemic countries in SEA Region have made significant progress since 2000. The Group identified operational and technical issues, and suggested appropriate remedial measures and to recommend an annual need of ALB for 2013. The meeting recommended the SEARO expanded RPRG focusing on LF, STH, trachoma and schistosomiasis and ensuring the sustenance of the gains already achieved in the LF elimination programme. The RPRG appreciated WHO/SEARO and the Member countries for the progress made to achieve elimination of LF by 2020.|
|Gov't Doc #:||SEA-CD-281|
|Appears in Collections:||Meeting Reports|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.